Viewing data from:

PAROXETINE MESYLATE

ANDA

PAROXETINE MESYLATE | A207188 | PRINSTON PHARMACEUTICAL INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: BRISDELLE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$2.69

per ea

Lowest NADAC/Unit

$2.69

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
43547040903PAROXETINE MESYLATE 7.5 MG CAP	$2.69	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDPAROXETINE MESYLATE

DMF 280912014

WANBURY LTDPAROXETINE MESYLATE

DMF 305732016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 7, 2017	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 7.5MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Aug 18, 2017

No patent or exclusivity listings for this strength.